Direkt zum Inhalt
Merck

HPLC Analysis of Benzodiazepines on Ascentis® Express Phenyl-Hexyl, Methanol Mobile Phase

HPLC Analysis of Benzodiazepines on Ascentis® Express Phenyl-Hexyl, Methanol Mobile Phase application for HPLC

Materialien

Analytische Säule

Produkt-Nr.
Beschreibung
Preisangaben

Ascentis® Express Phenyl-Hexyl, 2,7 μm HPLC-Säule

2.7 μm particle size, L × I.D. 5 cm × 4.6 mm

Standard

Produkt-Nr.
Beschreibung
Preisangaben

Desmethyldiazepam

analytical standard

Oxazepam -Lösung

1 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Alprazolam -Lösung

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Clonazepam -Lösung

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Diazepam -Lösung

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Ascentis Express Phenyl-Hexyl, 5 cm x 4.6 mm I.D., 2.7 μm particles (53348-U)

mobile phase

[A] water; [B] methanol; (35:65, A:B)

flow rate

1.4 mL/min

pressure

3600 psi (248 bar)

column temp.

35 °C

detector

UV, 250 nm

injection

2 μL

sample

0.1 g/L in 20% methanol

Beschreibung

Hinweis zur Analyse

The Phenyl-Hexyl phase of the Ascentis Express product line displays the best selectivity of this sample; selectivity is markedly affected by choice of organic modifier. The application also demonstrates feasibility of fast LC with Ascentis Express by virtue of low backpressure and high efficiency.

Rechtliche Hinweise

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany